CIK 0000949858 · Non-accelerated filer<br>Smaller reporting company
ACHIEVE LIFE SCIENCES, INC.
Sign in to watch- Tickers
- ACHV QUIT
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 954343413
- Phone
- 425-686-1500
- Business address
- 22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
- Former names
- ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
Securities
- ACHV Common stock Nasdaq
- QUIT Common Shares Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $175,177
- in 1 filing
Net −$175,177. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 8 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2008-08-21 | Cormack Scott Daniel President and CEO | Grant or award · Stock option (right to buy) | +21,559 | 21,559 | ||
| 2008-08-21 | Cormack Scott Daniel President and CEO | Grant or award · Stock option (right to buy) | +6,859 | 6,859 | ||
| 2008-08-21 | Cormack Scott Daniel President and CEO | Grant or award · Stock option (right to buy) | +46,167 | 46,167 | ||
| 2008-08-21 | JACOBS CINDY EVP, CMO | Grant or award · stock option (right to buy) | +27,221 | 27,221 | ||
| 2008-08-21 | Clendeninn Neil James Director | Grant or award · stock option (right to buy) | +2,395 | 2,395 | ||
| 2008-08-21 | Clendeninn Neil James Director | Grant or award · Stock option (right to buy) | +952 | 952 | ||
| 2008-08-21 | Clendeninn Neil James Director | Grant or award · Stock option (right to buy) | +3,702 | 3,702 | ||
| 2008-08-21 | Clendeninn Neil James Director | Grant or award · Stock option (right to buy) | +513 | 513 | ||
| 2008-08-21 | Clendeninn Neil James Director | Grant or award · Stock option (right to buy) | +3,048 | 3,048 | ||
| 2008-08-21 | Anderson Stephen Charles CFO and Secretary | Grant or award · stock option (right to buy) | +21,776 | 21,776 | ||
| 2008-08-21 | JACOBS CINDY Exec. VP & Chief Med. Officer | Grant or award · Stock Option (right to buy) | +27,203 | 27,203 | ||
| 2008-08-21 | Cormack Scott Daniel President & CEO | Grant or award | +1,306 | 1,306 | ||
| 2008-08-21 | Cormack Scott Daniel President & CEO | Grant or award | +1,015 | 1,015 | ||
| 2008-08-21 | Cormack Scott Daniel President & CEO | Grant or award · Stock Option (right to buy) | +24,809 | 24,809 | ||
| 2008-08-21 | Cormack Scott Daniel President & CEO | Grant or award · Stock Option (right to buy) | +870 | 870 | ||
| 2008-08-21 | Cormack Scott Daniel President & CEO | Grant or award · Stock Option (right to buy) | +7,073 | 7,073 | ||
| 2008-08-21 | Cormack Scott Daniel President & CEO | Grant or award · Stock Option (right to buy) | +20,457 | 20,457 | ||
| 2008-08-21 | Cormack Scott Daniel President & CEO | Grant or award · Stock Option (right to buy) | +6,528 | 6,528 | ||
| 2008-08-21 | Cormack Scott Daniel President & CEO | Grant or award · Stock Option (right to buy) | +21,545 | 21,545 | ||
| 2008-08-21 | Cormack Scott Daniel President & CEO | Grant or award · Stock Option (right to buy) | +6,855 | 6,855 |
Page 42 of 46 · 905 trades